Vir Biotechnology
VIR
#5504
Rank
ยฃ0.81 B
Marketcap
ยฃ5.89
Share price
0.54%
Change (1 day)
-26.76%
Change (1 year)
Categories

P/E ratio for Vir Biotechnology (VIR)

P/E ratio as of December 2024 (TTM): -3.78

According to Vir Biotechnology 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.78462. At the end of 2022 the company had a P/E ratio of 6.47.

P/E ratio history for Vir Biotechnology from 2019 to 2023

PE ratio at the end of each year

Year P/E ratio Change
20226.47-37.85%
202110.4-196.45%
2020-10.849.21%
2019-7.24

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-3.76-0.73%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.